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defibrillation achieved with a single lead right ventricular coil/defibrillator can
system.
PWO: 171.0, 1505 and 139.0 ms for each patient). With a cutoff <135.0 ms
for a normal PWO, the sensitivity was 78.5%, the specificity was 100%; the
positive predictive value was 100% and the negative was 75% for SAPW
to identify pts with WPWS and PAF. Conclusions: In the current study, pts
with WPWS and PAF showed prolonged intra-atrial conduction time when
compared with a control group. This may contribute to the development of
PAF.
11026-85\ Enhanced Defibrillation Efficacy with an Active
Pectoral Pulse Generator
RV/CAN 90mm2 160 mm2 617 mm2
OFT(J) 8.6 ± 3.3 8.1 ± 2.6 8.2 ± 2.5 4.9 ± 1.9*
Voltage (V) 373 ± 73 365 ± 58 367 ± 65 284 ± 53*
Impedance 74 ± 24 53 ± 13+ 48 ± 11+ 52 ± 10+
Conclusion: We found a poor correlation between the biphasic ULV and
the OFT using this clinically feasible followup technique. The ULV appears to
underestimate the OFT using this technique for evaluating ICO defibrillation
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*p value of monophasic vs biphasic. **p value of baseline vs LIDO
In 2 dogs, the OFT during LIDO was >50 joules with monophasic shock
and 27.9 ± 5.6 joules with biphasic shocks. LIDO caused a 13.1 ± 9.8%
increase in ventricular refractoriness (p < 0.037) and a 29.8 ± 22.7% increase
in GAS duration (p < 0.01). neither of which were predictive of OFT response.
Conclusion: Sodium channel blockade does increase the OFT of biphasic
shocks but to a lesser extent than observed with monophasic shock OFT's.
These results may have favorable implications for the use of Class I antiar-
rhythmics in patients with newer generation lCD's.
An active pectoral pulse generator can be incorporated in a single coil defib-
rillation lead system to achieve low defibrillation thresholds (OFT). However,
the incremental benefit of an active pulse generator with an integrated lead
system has not been evaluated. Accordingly, we performed a prospective
trial of a 65 cc pulse generator shell with an Endotak lead in 22 consecutive
pts undergoing defibrillator implantation. Energy (E) and leading edge volt-
age (V) at OFT was measured using a step down protocol to first failure with
biphasic waveforms (60:40 tilt). Either lead alone (proximal coil = anode) or
lead + shell (proximal coil and shell = anode) were tested with paired testing
in random order.
Michael B. Lenhart, Amir Saffarin, Steven O. Nelson. The Ohio State University,
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Several Class I antiarrhythmic drugs are known to increase the defibrillation
threshold 10FT) of monophasic shock waveforms delivered by implantable
defibrillators (ICD). The influence of sodium channel blockade on biphasic
shocks is unknown. The purpose of this study was to determine the effects
of lidocaine (LIDO) on the OFT with biphasic versus monophasic shock wave-
forms in an anesthetized canine model of transvenous defibrillation In =
101. The OFT was determined by the iterative increment-decrement proto-
col. Monophasic and biphasic shock OFT's were tested in random order at
baseline and during LIDO infusion (8 mg/kg load; 400 microgmlkg/min) and
presented below.
A DFT of :s10J was found in 50% (11/22) of patients with lead alone and
86% (19/22) of patients with lead + shell (p < 0.02).
In conclusion, adding an active pulse generator to an integrated transve-
nous lead significantly reduced OFTs and system impedance IRl. The consis-
tently low defibrillation energy requirements with the use of an active small
pectoral shell, makes the development of a defibrillator with reduced size
and lower maximal output feasible.
Andrea Russo, Lou-Anne Beauregard, Catherine Stubin, Harvey L. Waxman.
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We implanted nonthoracotomy defibrillators in consecutive pts with sus-
tained ventricular arrhythmias. A Ventritex Cadence (V-l00C) device using
a bipbasic waveform was implanted in all pts. The first 21 systems (Grp I)
consisted of a CPI (BT-1 0) endocardial lead at the AV apex for sensing and
pacing, with a CPIIC-l 0) spring electrode at the SVC/HAAjunction and a large
CPI patch (L67) implanted subcutaneously in the left axillary region for de-
fibrillation. A single lead defibrillation system (CPI Endotak C, Model #0064)
was implanted in 27 pts (Grp II). Mean age was 61 ± 12 years and LVEF
was 37 ± 16%, Three successful shocks for sustained VF were required to
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Impact of the Defibrillating Surface Area of an
Additional Superior Vena Cava Electrode on the
Unipolar Right Ventricular Coil/Defibrillator Can
System
ULV OFT
6.B ± 44 102 ± 5.5
r = 0.49, p ~ 0.11
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Background: The upper limit of vulnerability (ULV) is defined as the upper
limit of shock strength, above which ventricular fibrillation will not be induced
when the shock is delivered during the vulnerable period. ULV is postulated
to correlate with the defibrillation threshold (DFT) and, if true, should stream-
line implantable cardioverter-defibrillator (ICD) surgery and followup.
Methods and Results: We sought to determine whether the biphasic
ULV, measured with an easily implemented clinical protocol via the T-shock
method available in the 72190 Medtronic ICO using 65% tilt, 120 J.LF asym-
metric pulses, would correlate with the biphasic OFT assessed during follow
up electrophysiologic IEP) evaluation of ICD function. Twelve consecutive
patients were evaluated. The average age was 67 ± 3.4 years, LV ejection
fraction was 0.45 ± 0.04, and 58% had underlying CAD. The index arrhyth-
mia prompting ICO therapy was VF in 83% and VT in 17%. At the time of
the follow-up EP study, all patients had VF induced with T-shocks at 31 0 ms
following 3 ventricular paced beats at 400 ms starting at 0.2 Joules and step-
ping up until the ULVwas found as follows: 0.6, 1.0, 2.0, 3.0, 40, 5.0, 7.0,10,
14, and 18 Joules. The OFT was determined using the exact same waveform,
polarity and shock steps as was the ULV determination.
Results:
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We assessed the hypothesis that the surface area of an additional superior
vena cava (SVCI defibrillation electrode may impact on the defibrillation ef-
ficacy of a right ventricular (RV) coil/CAN system. In ten dogs we randomly
compared the energy requirements for defibrillation (OFT) using the AV/CAN
configuration and three triple lead systems employing an additional lead in
the SVC with a defibrillating surface area of 90 mm2, 160 mm2 and 617 mm2
respectively. Biphasic shocks with 65% fixed tilt were used for defibrillation.
Triplicate defibrillation thresholds were determined with each lead system.
With every electrode system the AV coil was used as cathode. Energy (J).
peak voltage (VI and impedance at defibrillation threshold are shown below:
*617 mm2 vs RV/CAN p < 0.01
+90 mm2 160 mm2, 617 mm2 vs RV/CAN p < 0.01
These results indicate that the surface area of an additional SVC defib-
rillating electrode may be critical to improving the energy requirement for
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